BeginNGS® Consortium announces Alexion, AstraZeneca Rare Disease as its first Platinum member
Company’s membership to support evolution of genome-informed newborn screening healthcare delivery system
2025-05-19
(Press-News.org) San Diego—May 19, 2025–Rady Children’s Institute for Genomic Medicine (RCIGM®) today announced that Alexion, AstraZeneca Rare Disease has signed on as the first Platinum member of the BeginNGS (pronounced “beginnings”) Consortium, building on an existing nine-year collaboration which has catalyzed innovation in rare disease diagnostics.
The BeginNGS Consortium seeks to accelerate adoption of newborn screening by whole genome sequencing to identify babies at risk for hundreds of genetic diseases and recommend effective therapies before symptoms arise. Membership of the Consortium reflects the breadth of the rare disease ecosystem, including leading organizations across healthcare delivery, biopharma, biotech, information technology, healthcare systems, providers and patient advocacy organizations. Platinum, Gold, Silver and Bronze members are expected to contribute their unique expertise and capabilities to advance genome-informed healthcare delivery that can scale to meet the needs of countries worldwide.
As the Consortium expands its programs and membership across the United States and internationally, platinum membership by Alexion will support the Consortium’s goal of implementing BeginNGS for 1,000 diseases in at least 10 countries by 2030.
Alexion, a pioneer of rare disease innovation for over 30 years, will provide strategic counsel, financial support and technical and scientific expertise and will continue to collaborate with additional members as the Consortium grows globally.
“Building on nearly a decade of partnership, we are excited to further strengthen our collaboration with Alexion as our first Platinum Member and together champion the promise of genomic medicine for rare diseases worldwide,” said Stephen Kingsmore, MD, DSc, President & CEO of RCIGM. “Through this increased level of support, Alexion will help us advance the implementation of genome-informed newborn screening with the goal of minimizing or preventing childhood suffering from genetic diseases.”
“Living with a rare disease is inherently inequitable, but by lessening the burden of the diagnostic odyssey, we can advance health equity solutions for patients with genetically based rare diseases and their families,” said Tom DeFay, PhD, Vice Chair of BeginNGS and Deputy Head of Diagnostics at Alexion. “We look forward to continuing to support the BeginNGS Consortium in this new capacity as it seeks to advance the global reach of critical diagnostic tools — the first step in the journey to care and treatment.”
About BeginNGS
Launched by RCIGM and its founding partners in 2022, BeginNGS is designed to prevent or minimize the effects of hundreds of childhood genetic diseases by identifying babies at risk and recommending effective therapies before symptoms arise. Our vision is to implement BeginNGS for 1,000 diseases by 2030 in at least 10 countries. This new phase of BeginNGS is supported by promising results of two studies recently published in The American Journal of Human Genetics showing that the BeginNGS technology platform reduces false positives by 97 percent, diagnoses genetic diseases earlier, and benefits one in 13 infants who might otherwise have tragic outcomes. BeginNGS currently screens for 412 severe childhood genetic diseases with effective interventions at multiple hospitals in the United States.
BeginNGS is made possible by the support and intellectual resources of BeginNGS Consortium members comprised of leading organizations in healthcare delivery, biopharma, biotech, information technology and patient advocacy, who are working together to create a new ecosystem for genome-informed healthcare delivery that can scale to meet the needs of countries worldwide.
END
ELSE PRESS RELEASES FROM THIS DATE:
2025-05-19
Emerging contaminants from rubber tires N-(1,3-Dimethylbutyl)-N'-phenyl-p-phenylenediamine (6PPD) and its oxidation product 6PPD-quinone (6PPDQ)—are raising new red flags for aquatic ecosystems. A recent study reveals that prolonged exposure to these chemicals at environmentally realistic levels disrupts lipid and carbohydrate metabolism, causes liver injury, and alters behavioral patterns in zebrafish. The research shows that 6PPD primarily accumulates in the liver, while 6PPDQ targets the brain. Both compounds downregulate PPARγ, a key regulator of metabolic function, and elevate pro-inflammatory cytokines, triggering chronic ...
2025-05-19
LOS ANGELES, May 19, 2025 — Two new studies examining mental health risks postpartum were published online today in the American Journal of Psychiatry in conjunction with Maternal Mental Health Awareness Month and the 2025 Annual Meeting of the American Psychiatric Association (APA). One study sought to estimate the risk of postpartum depression in people without a history of depression, and the other looked at the familial contribution to the risk of postpartum psychosis. Researchers from both studies were on hand to discuss their findings at a special briefing held at the APA meeting.
Risk for Postpartum Depression
Postpartum ...
2025-05-19
New Curtin University research has revealed that high densities of European honey bees could be harming Australian native bees’ ‘fitness’ by reducing their reproductive success and altering key traits linked to survival.
The study, led by Adjunct Research Fellow Dr Kit Prendergast from Curtin’s School of Molecular and Life Sciences, found that honey bees not only dominate pollen resources but may also affect the fitness of native cavity-nesting bees – with concerning consequences for biodiversity.
Dr Prendergast said the study used specially designed wooden ‘bee ...
2025-05-19
What inspired you to become a researcher?
I’ve always had a passion for nature and biodiversity, ever since I was a child (David Attenborough was, and still is, an inspiration). After completing my Honors project on horse behavior and publishing a review on the role of digging mammals in Australian ecosystems, when it came to conducting my PhD, I knew I wanted to do something that would make a real difference to conserving biodiversity.
I love research – unlike many people, I loved to study at university. I always knew I wanted to become a scientist, to advance our knowledge about biodiversity and further ...
2025-05-19
On an island off the coast of Panama lives a population of wild primates with a remarkable culture. White-faced capuchins on Jicarón Island in Coiba National Park use stone tools; and scientists have been monitoring this unique tradition with an array of motion-triggered cameras on the island since 2017. In 2022, doctoral researcher Zoë Goldsborough was looking through the camera trap footage when she found an unusual sighting, something they had never seen in the previous five years of data: a capuchin monkey ...
2025-05-19
About The Study: In this large cohort study of patients hospitalized with nonsevere COVID-19, there was no clinically meaningful difference in outcomes with early antibiotic treatment. Given the risks associated with unnecessary antibiotic treatment, these results argue against routine antibiotic use in this population.
Corresponding author: To contact the corresponding author, Michael S. Pulia, M.D., Ph.D., email mspulia@medicine.wisc.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi: 10.1001/jamanetworkopen.2025.11499)
Editor’s ...
2025-05-19
About The Study: In this cohort study, survivors of adolescence and young adulthood cancer reported significantly worse mental health trajectories into middle or older adulthood, compared with individuals who experienced cancer as adults or never had it. Cancer clinicians should recognize the mental health burden for this population into middle age and older adulthood.
Corresponding author: To contact the corresponding author, Anao Zhang, Ph.D., email zhangan@med.umich.edu.
To access the embargoed study: Visit our ...
2025-05-19
Researchers at the Francis Crick Institute have shown that mice use chemical cues, including odours, to detect the social rank of an unfamiliar mouse and compare it to their own, using this information to determine their behaviour.
Like many mammals, mice live in a social hierarchy where some are more dominant than others. This helps to avoid conflict and establish breeding partners.
It has been suggested previously that some mice might display fixed behaviour regardless of who they are interacting with, or that physical properties can give cues about social ranking. However, new research published ...
2025-05-19
An experimental drug developed at Duke University School of Medicine could offer powerful pain relief without the dangerous side effects of opioids.
The drug, called SBI-810, is part of a new generation of compounds designed to target a receptor on the nerves and spinal cord. While opioids flood multiple cellular pathways indiscriminately, SBI-810, a non-opioid treatment, takes a more focused approach, activating only a specific pain-relief pathway that avoids the euphoric “high” linked ...
2025-05-19
A new AI chip developed at the Technical University of Munich (TUM) works without the cloud server or internet connections needed by existing chips. The AI Pro, designed by Prof Hussam Amrouch, is modelled on the human brain. Its innovative neuromorphic architecture enables it to perform calculations on the spot, ensuring full cyber security. It is also up to ten times more energy efficient.
The professor of AI processor design at TUM has already had the first prototypes produced by semiconductor manufacturer Global Foundries in Dresden. Unlike conventional chips, the ...
LAST 30 PRESS RELEASES:
[Press-News.org] BeginNGS® Consortium announces Alexion, AstraZeneca Rare Disease as its first Platinum member
Company’s membership to support evolution of genome-informed newborn screening healthcare delivery system
